Login / Signup

Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled.

Joao Pedro FerreiraFaiez ZannadJaved ButlerGerasimos FilipattosIvana RitterElke SchülerBettina J KrausStuart J PocockStefan D AnkerMilton Packer
Published in: European heart journal (2022)
Empagliflozin reduced the incidence of hyperkalaemia without significant increase in hypokalaemia.
Keyphrases
  • heart failure
  • risk factors
  • left ventricular
  • acute heart failure
  • clinical trial